According to a recent LinkedIn post from PictorLabs, the company is emphasizing a shift in pathology and research toward maximizing the information derived from each tissue sample. The post highlights a “last slice” philosophy that focuses on smarter tissue preservation to reduce waste and extract more data from existing specimens.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that such approaches could improve workflow efficiency by generating more insights from the same volume of tissue, which may appeal to laboratories facing budget or sample constraints. For investors, this focus on sustainability and efficiency in digital pathology and virtual staining could position PictorLabs to capture demand from research institutions and healthcare providers seeking cost-effective, resource-conscious diagnostic technologies.